22-(Z)-hexacosenoic acid | 935444-46-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 22-(Z)-hexacosenoic acid
• 英文别名: (Z)-hexacos-22-enoic acid
• CAS: 935444-46-5
• 化学式: C₂₆H₅₀O₂
• 分子量: 394.682
• InChiKey: VUOUPHYLBXLIOC-PLNGDYQASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  11.6
• 重原子数：
  28
• 可旋转键数：
  23
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  在 甲醇 、 sodium hydroxide 、 盐酸 作用下， 以 水 为溶剂， 反应 2.0h， 以98%的产率得到22-(Z)-hexacosenoic acid
  参考文献：
  名称：

  WO2007/50668

  摘要：

  公开号：

文献信息

• ANALOGS OF ALPHA GALACTOSYLCERAMIDE AND USES THEREOF
  申请人：The Ludwig Institute for Cancer Research

  公开号：EP1945651B1

  公开（公告）日：2014-06-25
• Analogs of Alpha Galactosyceramide and Uses thereof
  申请人：Cerundolo Vincenzo

  公开号：US20090239813A1

  公开（公告）日：2009-09-24

  There are disclosed compound of formula I, in which R 1 represents a hydrophobic moiety adapted to occupy the C′ channel of human CDId, R 2 represents a hydrophobic moiety adapted to occupy the A′ channel of human CDId, such that R 1 fills at least at least 30% of the occupied volume of the C′ channel compared to the volume occupied by the terminal nC 14 H 29 of the sphingosine chain of α-galactosylceramide when bound to human CDId and R 2 fills at least 30% of the occupied volume of the A′ channel compared to the volume occupied by the terminal nC 25 H 51 of the acyl chain of α-galactosylceramide when bound to human CDId R 3 represents hydrogen or OH, R a and R b each represent hydrogen and in addition, when R 3 represents hydrogen, R a and R b together may form a single bond, X represents or —CHA(CHOH) n Y or —P(═0)(0 − )0CH 2 (CH0H) m Y, in which Y represents CHB 1 B 2 , n represents an integer from 1 to 4, m represents 0 or 1, A årepresents hydrogen, one of B 1 and B 2 represents H, OH or phenyl, and the other represents hydrogen or one of B 1 and B 2 represents hydroxyl and the other represents phenyl, in addition, when n represents 4, then A together with one of B 1 and B 2 together forms a single bond and the other of B 1 and B 2 represents H, OH or OSO 3 H and pharmaceutically acceptable salts thereof; the compounds of formula I are indicted for use in the treatment of a virus, microbial infection, parasite, an autoimmune disease, cancer, allergy or asthma
• US8039670B2
  申请人：——

  公开号：US8039670B2

  公开（公告）日：2011-10-18
• US8188313B2
  申请人：——

  公开号：US8188313B2

  公开（公告）日：2012-05-29
• US8334408B2
  申请人：——

  公开号：US8334408B2

  公开（公告）日：2012-12-18